Oral gefitinib plus methotrexate is not clinically superior to methotrexate for tubal ectopic pregnancy.

Published Date: 17 Feb 2023

A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...

Read Full News

Latest News

Prioritize Management of Ob/Gyn Patients’ Pain

Patients’ experience of pain during birth and ob/gyn procedures may relate to a perceived loss of control or a clinician’s lack of concern.

Blood Filtering May Extend Pregnancy With Preeclampsia

A small pilot study found that selectively filtering circulating protein sFlt-1 from maternal blood was safe and prolonged pregnancy in women with very preterm preeclampsia.

Be Prepared to Identify and Manage Maternal Sepsis

Maternal sepsis is rare in the US, but it is responsible for 24% of intrapartum deaths and 38.4% of postpartum maternal deaths.

Missed Sexual Health Assessment May Limit Clinical Insight

New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.

US Supreme Court Lets Abortion Pill Mail Delivery Restart for Now

The U.S. Supreme Court temporarily reinstated on Monday a federal rule allowing the abortion pill to be prescribed through telemedicine and dispensed through the mail,...

Home BP Testing Matches Usual Care in High-Risk Pregnancy

With outcomes on par with standard care, patients monitoring blood pressure at home had fewer clinic visits and hospitalizations.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

Patients’ experience of pain during birth and ob/gyn procedures may relate to a perceived loss of control or a clinician’s lack of concern.

A small pilot study found that selectively filtering circulating protein sFlt-1 from maternal blood was safe and prolonged pregnancy in women with very preterm preeclampsia.

Maternal sepsis is rare in the US, but it is responsible for 24% of intrapartum deaths and 38.4% of postpartum maternal deaths.

New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.

The U.S. Supreme Court temporarily reinstated on Monday a federal rule allowing the abortion pill to be prescribed through telemedicine and dispensed through the mail,...

With outcomes on par with standard care, patients monitoring blood pressure at home had fewer clinic visits and hospitalizations.

News All Time

IV Ferumoxytol Beats Oral Iron for Pregnancy Anemia

Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving hemoglobin at delivery and achieving better anemia resolution.

PRP Injection Improves Female Sexual Function

Platelet-rich plasma injections into the anterior vaginal wall enhance sexual function in premenopausal women.

Group and Individual Prenatal Care Yield Similar Experiences

No differences were observed between the two care models.

Male Factors, Female Burden: Rethinking Infertility Care

Delayed childbearing has increased pregnancies after age 35, and while assisted reproduction expands options, older parenthood raises clinical, social, and policy challenges.

Endometriosis: Recent Advances May Speed Time to Diagnosis

A new guideline from ACOG urges faster, nonsurgical diagnosis of endometriosis; research is identifying biomarkers that help simplify the process in the future.

Can Better Screening Prevent Maternal VTE Deaths?

Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.

Bed Rest Won’t Stop Preterm Birth in Women With Short Cervix

Activity restriction does not appear to lower the risk for preterm birth in pregnant women with a short cervix; it may even have the opposite effect.

Infodemic Threatens Women’s Clinical Decisions

1 in 5 French women says misinformation has already influenced their health decisions; nearly 40% of those women reported harm, including ineffective treatment or loss of trust.

Social Fund Can Be Used to Allow Access to Safe Abortions, EU

Member states may use an existing EU social fund to terminate pregnancies free of charge for women visiting ⁠from EU nations that restrict access to safe abortions.

Why Gender Matters for Antibiotic Dosing

A new review finds that women receive 25%-40% more antibiotics, experience up to twice as many adverse reactions, yet are underrepresented in trials; clinicians should adopt sex-aware prescribing.

South Korea Birthrate Rises Amid Signs of Easing Demographic Crisis

South Korea's birthrate rose for a second straight year in 2025, signalling that the country facing a demographic crisis for nearly a decade may be starting to turn a corner.

Preterm Birth Linked to Higher Disability Risk at Age 12

Children born extremely premature may have higher rates of neurodevelopmental disorders and impairments in cognitive, motor, and behavioral functions, according to a new study.

New Hospital Price Data Benefit Insurers More Than Patients

Trump made hospitals post prices so patients could shop, but the data are scarce and insurers, not patients, use these to bargain.

Is Chemsex’s Impact on Mental Health Underestimated?

Beyond sexual health risks, chemsex is linked to serious mental health consequences influenced by how often, how intensely and how substances are used.

Older C-Section Surgical Technique May Reduce Complications

As the number of cesarean sections has increased over the past 30 years, a faster surgical closure technique has gained widespread use but may increase long-term complications.

Menstruation topic still stigmatized by younger generation in Spain, study finds

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Recommended News For You

A new drug delivery system may help patients with a rare eye cancer

automated, precise reporting for clonality testing using NGS.

Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

Chemo causes lasting physical decline in breast cancer survivors

Mortality up for children with leukemia from lowest SES neighborhoods

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

Recommended Articles For You

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound 

Understanding Dasatinib: A Promising Drug for Cancer Treatment  

Unveiling the Mystery Behind Lymphovascular Invasion 

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

2.

No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma

3.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

4.

Home Screening Appeals to Women Facing Healthcare Barriers

5.

Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.

1.

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer 

2.

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology

3.

Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy 

4.

Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment

5.

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

4.

Efficient Management of First line ALK-rearranged NSCLC

5.

Navigating the Complexities of Ph Negative ALL - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot